Li-Cycle: BMO Cuts Target After Negative Revenues Recorded In Q3

Li-Cycle (NYSE: LICY) recently reported its third-quarter financial results. The company reported revenues of -$2 million; this was due to an “unfavorable non-cash fair market value (FMV) pricing adjustment of $(7.3) million relating to prior-period black mass sales.” This made the company’s product sale segment come in at -$2.34 million, and recycling service revenues came in at $0.373 million.

Operating expenses for the quarter were $32.5 million, of this, share-based compensation was $4 million, and salaries and benefits came in at $9.5 million. Professional fees came in at $4.2 million. This brought the company’s net income to -$27.5 million, or earnings per share of -$0.16.

The company ended the quarter with $649 million of cash on hand and about $285 million in long-term convertible debt. The company said that it continues to evaluate multiple capital sources, such as debt and funding from potential strategic partners.

Li-Cycle currently has eight analysts covering the stock with an average 12-month price target of US$10.13, or an upside of 61%. Out of the eight analysts, two have strong buy ratings, four have buy ratings and the last two analysts have hold ratings. The street high price target sits at US$13 and represents an upside of 107%.

In BMO Capital Markets’ note on the results, they reiterated their outperform rating but cut their 12-month price target to $10 from $12, saying that they acknowledge that the stock could trade sideways until the Rochester Hub-plant completion which is expected to be around the end of 2023, and expects there to be more growing pains ahead.

Even with that, BMO writes, “Li-Cycle is still a well-capitalized first-mover as a Western battery recycler; is well positioned to benefit from various government led OpEx/funding assistance programs to be deployed over the near-term; and is backstopped by further moat support given its Tier-1 partners.”

As a result of the earnings, BMO has reset its expectations on earnings going forward. They now expect EBITDA to be $225 million in 2025 with an EBITDA margin of 44%. Additionally, with the Rochester Hub expected to be done by late 2023, they expect a company de-risking to happen during 2024.

As a result of this, BMO now expects that the Hub-2 start-up will happen roughly 2 to 3 years after the Richester Hub is completed. Additionally, they expect Li-Cycle to get a 10% OpEx subsidy to their US recycling plants. Subsidies will primarily be for processing costs and not battery metal feedstock.

Below you can see BMO Capital Markets’ updated estimates on Li-Cycle.


Information for this briefing was found via Edgar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver’s Next Move May Be Built on a Much Stronger Base | Mani Alkhafaji – First Majestic Silver

Guanajuato Silver Q1 Earnings: They Finally Post Positive Net Income

We’re in a New Era of Gold Price Discovery | Ryan King – Equinox Gold

Recommended

Silver47 Starts 10,000 Metre Campaign at Flagship Alaska Silver Project

Blue Jay Gold Launches 16,000 Metre Drill Program At Steller

Related News

Medipharm Labs Receives Price Target Reduction From Canaccord To $1.75

Yesterday, On November 16th, Medipharm Labs (TSX: LABS) reported their third quarter financial results. Reported...

Tuesday, November 17, 2020, 03:37:00 PM

Patriot One Sees Canaccord Reduce Price Target To $0.75 Following Delays

Thursday, Canaccord Genuity’s Doug Taylor lowered Patriot One’s (TSX: PAT) 12-month price target from C$1.15...

Saturday, October 17, 2020, 01:42:00 PM

Canaccord: “We Expect Kinross’s Trailing 4Q Free Cash Flow To Surpass $800 Million In Q4”

Yesterday, Kinross Gold (TSX: K) released its third quarter financial results. The company reported adjusted...

Thursday, November 5, 2020, 12:27:00 PM

Cantor Releases Industry Report For Cannabis, Aphria Remains Top Pick

Recently, Cantor Fitzgerald released their monthly review of Hifyre data for the four weeks ending...

Sunday, October 4, 2020, 01:57:00 PM

Curaleaf: Canaccord Raises Price Target To $23.50

Wednesday, Canaccord came out with their updated valuations for the large three multi-state operators. In...

Saturday, January 16, 2021, 01:43:00 PM